NATIONAL INSTITUTES OF HEALTH ISSUES NOTICE: GOVERNMENT OWNED INVENTIONS AVAILABLE FOR LICENSE: GAIT ASSISTANCE SYSTEMS AND METHODS OF CONTROL THEREOF

WASHINGTON, Feb. 13 -- National Institutes of Health has issued a notice called: Government Owned Inventions Available for License: Gait Assistance Systems and Methods of Control Thereof. The notice ... Read More

NATIONAL INSTITUTES OF HEALTH ISSUES NOTICE: PROSPECTIVE GRANT OF AN EXCLUSIVE PATENT LICENSE: IN VIVO MANUFACTURED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) PRODUCTS FOR THE TREATMENT OR PREVENTION OF B CELL MEDIATED AUTOIMMUNE DISEASES

WASHINGTON, Feb. 13 -- National Institutes of Health has issued a notice called: Prospective Grant of an Exclusive Patent License: In Vivo Manufactured Anti-CD19 Chimeric Antigen Receptor (CAR) Produc... Read More

FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: DETERMINATION OF REGULATORY REVIEW PERIOD FOR PURPOSES OF PATENT EXTENSION; AUCATZYL

WASHINGTON, Feb. 13 -- Food and Drug Administration has issued a notice called: Determination of Regulatory Review Period for Purposes of Patent Extension; AUCATZYL. The notice was published in the F... Read More

FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: DETERMINATION OF REGULATORY REVIEW PERIOD FOR PURPOSES OF PATENT EXTENSION; CRENESSITY

WASHINGTON, Feb. 13 -- Food and Drug Administration has issued a notice called: Determination of Regulatory Review Period for Purposes of Patent Extension; CRENESSITY. The notice was published in the... Read More

FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: DETERMINATION OF REGULATORY REVIEW PERIOD FOR PURPOSES OF PATENT EXTENSION; ALYFTREK

WASHINGTON, Feb. 13 -- Food and Drug Administration has issued a notice called: Determination of Regulatory Review Period for Purposes of Patent Extension; ALYFTREK. The notice was published in the F... Read More

FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: DETERMINATION OF REGULATORY REVIEW PERIOD FOR PURPOSES OF PATENT EXTENSION; BLUJEPA

WASHINGTON, Feb. 13 -- Food and Drug Administration has issued a notice called: Determination of Regulatory Review Period for Purposes of Patent Extension; BLUJEPA. The notice was published in the Fe... Read More

FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: DEFINING DURATIONS OF USE FOR APPROVED MEDICALLY IMPORTANT ANTIMICROBIAL DRUGS FED TO FOOD-PRODUCING ANIMALS; GUIDANCE FOR INDUSTRY; AVAILABILITY

WASHINGTON, Feb. 13 -- Food and Drug Administration has issued a notice called: Defining Durations of Use for Approved Medically Important Antimicrobial Drugs Fed to Food-Producing Animals; Guidance f... Read More

FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: DETERMINATION OF REGULATORY REVIEW PERIOD FOR PURPOSES OF PATENT EXTENSION; KEBILIDI

WASHINGTON, Feb. 13 -- Food and Drug Administration has issued a notice called: Determination of Regulatory Review Period for Purposes of Patent Extension; KEBILIDI. The notice was published in the F... Read More

FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: DETERMINATION OF REGULATORY REVIEW PERIOD FOR PURPOSES OF PATENT EXTENSION; RYTELO

WASHINGTON, Feb. 13 -- Food and Drug Administration has issued a notice called: Determination of Regulatory Review Period for Purposes of Patent Extension; RYTELO. The notice was published in the Fed... Read More

FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: DETERMINATION OF REGULATORY REVIEW PERIOD FOR PURPOSES OF PATENT EXTENSION; AMTAGVI

WASHINGTON, Feb. 13 -- Food and Drug Administration has issued a notice called: Determination of Regulatory Review Period for Purposes of Patent Extension; AMTAGVI. The notice was published in the Fe... Read More

• ««
• «
• 809
• 810
• 811
• 812
• 813
• 814
• 815
• 816
• 817
• 818
• »
• »»